Home - Products - Others - Other Targets - [Arg8]-Vasotocin TFA (113-80-4 free base)

[Arg8]-Vasotocin TFA (113-80-4 free base)

CAS No. ——

[Arg8]-Vasotocin TFA (113-80-4 free base)( —— )

Catalog No. M30051 CAS No. ——

[Arg8]-Vasotocin (TFA) is a nonmammalian vertebrate neurohypophyseal peptide.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    [Arg8]-Vasotocin TFA (113-80-4 free base)
  • Note
    Research use only, not for human use.
  • Brief Description
    [Arg8]-Vasotocin (TFA) is a nonmammalian vertebrate neurohypophyseal peptide.
  • Description
    [Arg8]-Vasotocin (TFA) is a nonmammalian vertebrate neurohypophyseal peptide.(In Vitro):[Arg8]-Vasotocin occurs throughout the vertebrate phyla, being present in primitive fish, the cyclostomes, and remaining unchanged in vertebrates up to and including birds. [Arg8]-Vasotocin excites neurones in the dorsal vagal complex in vitro.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    ——
  • Formula Weight
    1164.24
  • Molecular Formula
    C45H68F3N15O14S2
  • Purity
    >98% (HPLC)
  • Solubility
    H2O : 50 mg/mL (42.95 mM; Need ultrasonic)
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

Ingram CD, et al [Arg8]vasotocin excites neurones in the dorsal vagal complex in vitro: evidence for an action through novel class(es) of CNS receptors. J Neuroendocrinol. 1994 Aug;6(4):415-22.
molnova catalog
related products
  • Iodipamide

    A water-soluble radiographic contrast media for cholecystography and intravenous cholangiography.

  • Examorelin

    Examorelin is an agonist of growth hormone-releasing factor (GHRF), and for the treatment of cardiac diseases.hexarelin treatment protected cardiac function in the chronic phase as evidenced by higher ejection fraction and fractional shortening, as well as lower lung weight/body weight and lung weight/tibial length ratios, compared with vehicle treatment.?

  • Bisoxatin

    Bisoxatin (LA 271A) is an oral laxative that can be used to study contact laxatives for chronic constipation.